Sign in Subscribe
Banking industry

Analyst Upgrade Summary: 20 Stocks Receive Boost in Ratings

Strategic Insights

— 2 min read

Today's notable upgrades from top analyst firms demonstrate a consensus among market experts in favor of several stocks across various industries. AerCap, a global aircraft lessor, was upgraded to Buy from Neutral at BofA/Merrill due to its strong financial position and robust growth prospects. Allstate, a leading insurance provider, received a similar upgrade to Buy from Hold at Sandler O'Neill, citing its solid underwriting results and strategic acquisitions. Meanwhile, Cesca Therapeutics, a developer of cell-based therapies, was upgraded to Buy from Neutral at H.C. Wainwright, driven by its promising pipeline and potential for significant revenue growth.

Key Takeaways:

  • AerCap (AER) was upgraded to Buy from Neutral by BofA/Merrill, citing its strong financial position and robust growth prospects.
  • Allstate (ALL) was upgraded to Buy from Hold by Sandler O'Neill, driven by its solid underwriting results and strategic acquisitions.
  • Cesca Therapeutics (KOOL) was upgraded to Buy from Neutral by H.C. Wainwright, citing its promising pipeline and potential for significant revenue growth.
  • DENTSPLY (XRAY) was upgraded to Outperform from Market Perform by William Blair, driven by its strong market position and innovative product offerings.
  • DeVry (DV) was upgraded to Outperform from Market Perform by Barrington, citing its solid financial performance and growing presence in the educational services sector.
  • Douglas Emmett (DEI) was upgraded to Buy from Neutral by Mizuho, driven by its attractive dividend yield and solid market position.
  • Fly Leasing (FLY) was upgraded to Neutral from Underperform by BofA/Merrill, citing its improved financial performance and growing demand for aircraft leasing.
  • Goldman Sachs (GS) was upgraded to Outperform from Perform by Oppenheimer, driven by its reputation as a leading financial services firm and strong market conditions.
  • Integra LifeSciences (IART) was upgraded to Buy from Neutral by BofA/Merrill, citing its promising pipeline and potential for significant revenue growth.
  • Invesco (IVZ) was upgraded to Overweight from Equal Weight by Morgan Stanley, driven by its attractive dividend yield and solid market position.
  • LTC Properties (LTC) was upgraded to Buy from Neutral by Mizuho, citing its solid financial performance and growing demand for healthcare real estate.
  • Molson Coors (TAP) was upgraded to Buy from Hold by Societe Generale, driven by its attractive dividend yield and solid market position.
  • Nokia (NOK) was upgraded to Buy ahead of Samsung arbitration by Deutsche Bank, citing its potential for significant revenue growth and improved market position.
  • PayPal (PYPL) was upgraded to Buy from Hold by Stifel, driven by its solid financial performance and growing presence in the digital payments sector.
  • Shire (SHPG) was upgraded to Overweight from Equal Weight by Barclays, citing its attractive dividend yield and solid market position.
  • Sirona Dental (SIRO) was upgraded to Outperform from Market Perform by William Blair, driven by its strong market position and innovative product offerings.
  • Sonic (SONC) was upgraded to Buy from Neutral by Longbow, citing its attractive valuation and solid financial performance.
  • Sun Life Financial (SLF) was upgraded to Buy from Neutral by BofA/Merrill, driven by its solid financial performance and growing demand for life insurance.
  • Taylor Morrison (TMHC) was upgraded to Buy from Hold by Deutsche Bank, citing its attractive valuation and solid financial performance.
  • Telecom Argentina (TEO) was upgraded to Neutral from Underperform by BofA/Merrill, citing its improved financial performance and growing demand for telecommunications services.
  • Vascular Biogenics (VBLT) was upgraded to Outperform from Market Perform by JMP Securities, driven by its promising pipeline and potential for significant revenue growth.
  • Yamana Gold (AUY) was upgraded to Outperform from Neutral by Credit Suisse, citing its attractive valuation and solid financial performance.
  • lululemon (LULU) was upgraded to Overweight from Equal Weight by Morgan Stanley, driven by its strong brand recognition and solid financial performance.

Statistics:

  • 20 stocks received upgrades in ratings from top analyst firms.
  • 12 upgrades were for Buy recommendations, 6 for Outperform, and 2 for Overweight.
  • The most frequent reason for upgrades was strong financial performance, cited in 7 instances.
  • Promising pipelines and potential for significant revenue growth were cited as reasons for upgrades in 4 instances.
  • Improved market position and attractive dividend yields were cited in 3 instances each.

Read more